Internal Medicine, Rheumatology · Boston, MA
NPI
1730348111
Since 2008
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
725 Albany St, Shapiro 7 Suite B
Boston, MA, 02118
Phone (617) 638-1460
Groups this clinician bills Medicare through
Medicare paid, 2024
$27K
438 services
Medicare patients, 2024
161
Average age 68
Drug cost, 2024
$2.8M
2,636 prescriptions
Company payments, 2025
$11K
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Marcin A Trojanowski was code 99214 (office e&m - established), 154 times for 92 patients. In total Marcin A Trojanowski billed 438 services in 18 codes, and Medicare paid $27K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-10-05.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Facility | 154 | 92 | $74.26 | $11K |
| 20610 Joint Injection | Facility | 59 | 30 | $42.43 | $2,503 |
| 99213 Office E&M - Established | Facility | 53 | 39 | $50.48 | $2,675 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 50 | 41 | $13.54 | $677 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 19 | 12 | $13.82 | $263 |
| 99213 Office E&M - Established | Office | 15 | 12 | $79.23 | $1,188 |
| 99204 Office E&M - New | Facility | 12 | 12 | $95.89 | $1,151 |
| 99215 Office E&M - Established | Facility | 11 | 11 | $119.66 | $1,316 |
| 99203 Office E&M - New | Facility | 11 | 11 | $62.15 | $684 |
By year: 2022 $25K for 373 services; 2023 $25K for 383 services; 2024 $27K for 438 services.
Medicare prescription drug claims, 2024
In 2024, the drug Marcin A Trojanowski prescribed most often to Medicare patients was Methotrexate (Methotrexate Sodium), with 273 prescriptions and refills. In total Marcin A Trojanowski wrote 2,636 Medicare prescriptions that cost $2.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Methotrexate Methotrexate Sodium | 273 | 353 | 47 | $5,993 |
| Prednisone Generic | 187 | 208 | 48 | $974 |
| Celecoxib Generic | 179 | 194 | 34 | $3,744 |
| Mycophenolate Mofetil Generic | 143 | 201 | 24 | $15K |
| Hydroxychloroquine Sulfate Generic | 143 | 219 | 37 | $5,229 |
| Gabapentin Generic | 126 | 126 | 23 | $1,928 |
| Omeprazole Generic | 113 | 192 | 21 | $1,311 |
| Humira Pen Adalimumab | 96 | 96 | 14 | $763K |
| Diclofenac Sodium Generic | 71 | 73 | 21 | $1,900 |
| Tramadol Hcl Generic | 70 | 70 | 15 | $524 |
| Xeljanz Xr Tofacitinib Citrate | 66 | 66 | Under 11 | $363K |
| Pantoprazole Sodium Generic | 59 | 83 | Under 11 | $378 |
| Amlodipine Besylate Generic | 55 | 79 | Under 11 | $296 |
| Actemra Actpen Tocilizumab | 53 | 60 | Under 11 | $277K |
| Sildenafil Citrate Generic | 52 | 60 | Under 11 | $5,148 |
Brand drugs: - claims; generic drugs: 2,158 claims; opioid claims: 153.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Marcin A Trojanowski $11K ($11K in general payments such as food, travel and fees) from 3 companies. The largest payer was Boehringer Ingelheim Pharmaceuticals, Inc. with $9,058.
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $9,058 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $2,078 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.